- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 281
Altair lands NewFasant
Altair has picked up computational electromagnetics software developer NewFasant, based on the research of University of Alcalá associate professor Lorena Lozano Plata.
Jan 7, 2020ETH Zurich yields 30 spinouts in 2019
ETH Zurich's portfolio attracted a record $649m in funding last year, and the university also spawned more businesses year-on-year.
Jan 7, 2020Insight Partners imports Armis in $1.1bn deal
Insight Partners is acquiring the IoT security software provider through a transaction that will include $100m from Alphabet subsidiary CapitalG.
Jan 7, 2020ECBF sees Brandkamp to general partner position
Michael Brandkamp has departed from its managing director role at corporate-backed fund HTGF to become a general partner European Circular Bioeconomy Fund.
Jan 7, 2020Daily deal net: January 6, 2020
Today’s deal net captures the smaller investments from across the university innovation ecosystem over the past two weeks.
Jan 6, 2020Oxford Nanopore sequences $38.5m
The University of Oxford DNA processing spinout tapped a consortium of unnamed investors in a round which also includes $106m in secondary funding.
Jan 6, 2020Receipt Bank reaps $73m
Canadian Imperial Bank of Commerce contributed to the digital accounting platform developer's series C round, taking its total funding past $130m.
Jan 6, 2020Oxford Nanopore extracts more funding
The Illumina and Amgen-backed genetic sequencing system developer raised $38.5m while its shareholders sold another $106m in shares.
Jan 6, 2020Corporate venturing deal net: 23 December 2019-3 January 2020
In an extended version covering the holidays, Global Corporate Venturing has rounded up the period’s smaller deals and tracked the emerging companies accessing corporate funds.
Jan 3, 2020Corporates sweeten $278m fund for Truffle Capital
Guerbet, Caisse Centrale de Réassurances, L’Occitane and Sopra Steria were among the backers for the life sciences-focused venture firm's BioMedTech fund.
Dec 23, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


